US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 2.810
  • 0.0000.00%
Trading Nov 8 10:19 ET
585.10MMarket Cap-2036P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
25.07M
+166.77%
EPS
-0.04
+93.24%
Analyst Rating
Buy

Nov 6, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 8.129M --
Nov 12, 2024 2024/Q3 -- / 25.071M --
Aug 6, 2024 2024/Q2 356.000K / 8.260M --
May 9, 2024 2024/Q1 481.000K / 6.361M --
-- 2023/Q4 2.042M / 8.105M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 8.129M--
Nov 12, 20242024/Q3-- / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

  • Sangamo Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:07

  • Sangamo Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 04:10

  • Sangamo Therapeutics | 10-K: FY2023 Annual Report

    Mar 13 19:53

  • Sangamo Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 04:17

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Buy

    • Buy

      60.00%

    • Hold

      40.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Gene Editing
    Gene Editing
    Intraday+1.33%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-2.25%